Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_assertion description "[Aromatase inhibitors (AI) that inhibit breast cancer cell growth by blocking estrogen synthesis have become the treatment of choice for post-menopausal women with estrogen receptor positive (ER+) breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_assertion evidence source_evidence_literature NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_assertion SIO_000772 21658239 NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_assertion wasDerivedFrom befree-2016 NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_assertion wasGeneratedBy ECO_0000203 NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.
- befree-2016 importedOn "2016-02-19" NP900723.RAdyIXHwHr6E9Cb2m9NxhPyN3PWm-660ZZ6XKRx3wRPWY130_provenance.